Table 3.
| Design | T/t group | Baseline | 1 week | % reduction | 2 weeks | % reduction |
|---|---|---|---|---|---|---|
| Lycopene | OP | 1.80 ± 0.84 | 0.80 ± 0.45* | 55.56 ± 7.74 | 0.60 ± 0.55* | 66.67 ± 5.75# |
| Non-OP | 1.60 ± 0.55 | 1.20 ± 0.45* | 25.0 ± 3.03 | 0.80 ± 0.45* | 50.0 ± 3.03 | |
| Placebo | OP | 1.60 ± 0.55 | 0.80 ± 0.45* | 50.0 ± 3.03 | 0.60 ± 0.55* | 62.5 ± 2.94 |
| Non-OP | 2.00 ± 0.71 | 1.60 ± 0.55 | 2.00 ± 1.76 | 1.80 ± 0.71 | 10.0 ± 5.76 |
* Statistically significant (p < 0.05) within the group.
# Statistically significant relative to NOP-placebo (p < 0.001).